STACY HEAD: Open Payments
NPI 1174886329 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$194 in 12 payments from 7 companies in 2025. Trend: 2023 $128 · 2024 $217 · 2025 $194
Food & beverage: $194
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $42 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Amgen Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $4 |
Products named: CAMZYOS, LEQVIO, FANAPT, SHINGRIX, REPATHA, VERQUVO, ELIQUIS, LifeVest.
Industry payments across KY — which companies pay providers there.
